Rain Oncology is a clinical-stage company researching, developing and translating innovative targeted therapies for patients with cancer to help provide them hope to get their lives back. Our therapies target oncogenic drivers to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology.
| Website | https://www.rainoncology.com/ |
| Revenue | $7.8 million |
| Employees | 7 (4 on RocketReach) |
| Founded | 2017 |
| Address | 8000 Jarvis Ave Suite 204, Newark, California 94560, US |
| Phone | +1 510-953-5559 |
| Technologies |
JavaScript
,
HTML
,
PHP
+38 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Oncology, Cancer Therapies, Targeted Therapies, Clinical Stage, Cancer Treatment, Drug Development, Biotechnology, Pharmaceutical, Cancer Research, Innovative Therapies, Precision Medicine, Genetic Testing, Clinical Trials, New Cancer Treatments, Personalized Medicine, Molecular Oncology, Drug Discovery, Therapeutic Development |
| Competitors | Foundation Medicine, Guardant Health, Caris Life Sciences, Invitae, Freenome, NantHealth, Tempus Labs, Inc., Exact Sciences, Biocept, Inc., Oncocyte Corporation +35 more (view full list) |
Looking for a particular Rain Oncology employee's phone or email?
The Rain Oncology annual revenue was $7.8 million in 2026.
Steve Flint is the Vice President, People and Culture of Rain Oncology.
4 people are employed at Rain Oncology.
Rain Oncology is based in Newark, California.